Retinoblastoma
-
Daniels receives research grant from Knights Templar Eye Foundation to study retinoblastoma treatment
Vanderbilt investigator Anthony Daniels has received a grant from the Knights Templar Eye Foundation to develop new, safe and effective treatments for retinoblastoma, the most common ocular cancer in children. Read MoreJun 25, 2015
-
Novel therapy eases stress of retinoblastoma treatment
Conventional therapy for patients diagnosed with retinoblastoma, the most common ocular cancer in children, includes systemic chemotherapy, external beam radiation and/or surgical removal of the eye. Doctors at Vanderbilt University Medical Center are on track to radically change the way the disease is treated using an emerging therapeutic approach called intra-arterial chemotherapy, or IA chemo. Read MoreOct 9, 2014